ctDNA predicts early treatment response in HPV-associated anal cancer
Dr Lizzel van der Snee (Netherlands Cancer Institute, Amsterdam, Netherlands), Dr Max Lahaye (Netherlands Cancer Institute, Amsterdam, Netherlands) and Dr Niels Kok (Netherlands Cancer Institute, Amsterdam, Netherlands) discuss the DISCO trial.
In this trial, preoperative diffusion-weighted MRI significantly improved staging accuracy and reduced futile surgical procedures in patients with colorectal peritoneal metastases considered for cytoreductive surgery.
DW-MRI–guided staging lowered the rate of unnecessary operations compared with standard staging (27.4% vs 43.3%, P=0.0093) and reduced the need for staging laparoscopy.
Dr van der Snee highlights the benefit was most pronounced in the Dutch cohort, where laparoscopy was not routinely performed.
These findings support DW-MRI as a valuable addition to preoperative evaluation to better select patients for CRS and minimise avoidable morbidity.
ctDNA predicts early treatment response in HPV-associated anal cancer
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Customised colorectal cancer early diagnosis programme can identify advanced adenomas and early-stage cancer
SABCS 2025: Latest developments in multigene testing in early breast cancer
AI and pathology reveal higher late recurrence risk in invasive lobular breast cancer
AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab
MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection
ctDNA testing improves detection of treatable metastases compared to standard care in colorectal cancer
Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration